High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation

This publication has 14 references indexed in Scilit:

• Graft-versus-Tumor Effect Against Advanced Pancreatic Cancer after Allogeneic Reduced-Intensity Stem Cell Transplantation
  Transplantation, 2005
• Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
  Blood, 2003
• Endothelial damage caused by cytomegalovirus and human herpesvirus-6
  Bone Marrow Transplantation, 2003
• Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
  Blood, 2002
• Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin
  Bone Marrow Transplantation, 2002
• Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes
  Blood, 2001
• Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan
  Bone Marrow Transplantation, 2001
• Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease
  Bone Marrow Transplantation, 1998
• Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind Trial
  Annals of Internal Medicine, 1993
• Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant
  Annals of Internal Medicine, 1993